Andrew Kruegel

Andrew_Kruegel

2015-2016

I am developing improved analogs of the known antidepressant, tianeptine, which acts through a novel mechanism of action, as new therapies for treatment-resistant depression

Newsletter Signup

Corporate Supporters

Community Service Providers